PIK3CA-Related Overgrowth Spectrum Latest Advances

Find the Latest Research About PIK3CA-Related Overgrowth Spectrum

Last Updated: 06/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8684 publications

Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study.

Multimodal artificial intelligence predicts PIK3CA mutation in breast cancer from digital pathology and clinical data: a multicenter study.

Journal: Cancer biology & medicine

Published: April 13, 2026

Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer.

Integrative multi-omic analysis identified ERBB2 mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer.

Journal: Cancer biology & medicine

Published: April 13, 2026

Clinicogenomic Landscape and Function of PIK3CA, AKT1, and PTEN Mutations in Breast Cancer.

Clinicogenomic Landscape and Function of PIK3CA, AKT1, and PTEN Mutations in Breast Cancer.

Journal: JCO precision oncology

Published: April 09, 2026

Adenocarcinoma of Mammary Gland Type of the Vulva.

Adenocarcinoma of Mammary Gland Type of the Vulva.

Journal: International journal of surgical pathology

Published: April 07, 2026

Fully Automated Abstraction of Longitudinal Breast Oncology Records with Off-The-Shelf Large Language Models.

Fully Automated Abstraction of Longitudinal Breast Oncology Records with Off-The-Shelf Large Language Models.

Journal: medRxiv : the preprint server for health sciences

Published: April 03, 2026

PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy.

PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy.

Journal: Neoplasia (New York, N.Y.)

Published: April 01, 2026

Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.

Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.

Journal: JCO precision oncology

Published: March 30, 2026

Combined exposure effects and potential mechanisms of volatile organic compounds on liver fibrosis in the US population: An integrative epidemiological and computational toxicology analysis.

Combined exposure effects and potential mechanisms of volatile organic compounds on liver fibrosis in the US population: An integrative epidemiological and computational toxicology analysis.

Journal: Toxicology mechanisms and methods

Published: March 30, 2026

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy.

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy.

Journal: JCO precision oncology

Published: March 30, 2026

Extra-Appendiceal Goblet Cell Adenocarcinoma: Clinicopathological Features of a Series of Tumors in the Gastrointestinal Tract and Bile Duct.

Extra-Appendiceal Goblet Cell Adenocarcinoma: Clinicopathological Features of a Series of Tumors in the Gastrointestinal Tract and Bile Duct.

Journal: International journal of surgical pathology

Published: March 26, 2026

Discovery of Novel Disubstituted l-Prolinamide Derivatives as Selective PI3Kα Inhibitors for Anticancer Therapy.

Discovery of Novel Disubstituted l-Prolinamide Derivatives as Selective PI3Kα Inhibitors for Anticancer Therapy.

Journal: Journal of medicinal chemistry

Published: March 18, 2026

Integrating Network Pharmacology, Transcriptome Analysis, and In Vitro Experiment to Investigate Molecular Mechanism of Liensinine on Pancreatic Cancer.

Integrating Network Pharmacology, Transcriptome Analysis, and In Vitro Experiment to Investigate Molecular Mechanism of Liensinine on Pancreatic Cancer.

Journal: DNA and cell biology

Published: March 18, 2026

Showing 1-12 of 8,684

Last Updated: 06/24/2026